Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
martedì, settembre 29
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Regenxbio Inc
RGNX
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$7.47
0.07
0.95%
In chiusura: Sep 25, 5:00 PM EST
$7.51
0.11
1.49%
Pre-mercato: 6:20 AM EST
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Opzioni
Rapporto azionario
Regenxbio Analyst Price Targets
Wall Street analyst price targets and consensus rating for Regenxbio (RGNX).
Analyst Ratings News
PRO
HC Wainwright & Co. Maintains Buy on Regenxbio, Lowers Price Target to $21
HC Wainwright & Co. analyst Yi Chen maintains Regenxbio (NASDAQ:RGNX) with a Buy and lowers the price target from $23 to $21.
Benzinga Newsdesk
PRO
Baird Maintains Outperform on Regenxbio, Lowers Price Target to $29
Baird analyst Brian Skorney maintains Regenxbio (NASDAQ:RGNX) with a Outperform and lowers the price target from $32 to $29.
Benzinga Newsdesk
This NetApp Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Monday
Wall Street analysts upgraded PTGX, LECO, and JHX. See analyst ratings and price targets for these stocks.
Avi Kapoor
PRO
HC Wainwright & Co. Maintains Buy on Regenxbio, Lowers Price Target to $23
HC Wainwright & Co. analyst Yi Chen maintains Regenxbio (NASDAQ:RGNX) with a Buy and lowers the price target from $26 to $23.
Benzinga Newsdesk
This Tower Semiconductor Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Friday
Wall Street analysts changed outlook on top names. For rating changes, check our analyst ratings page. See analysts' views on ADIG, TSEM and more
Avi Kapoor
This HubSpot Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Top Wall Street analysts changed outlook on top names. For all changes & stock ratings, see analyst ratings page. Some stocks downgraded & price targets lowered.
Avi Kapoor
Privacy Manager
Crea una watchlist
GRATIS: Segui le azioni e criptovalute con le migliori notifiche di internet
Clicca per iniziare
People Also Watch
AbbVie Inc
NYSE:ABBV
$267
0.27%
Amgen Inc
NASDAQ:AMGN
$418.13
-%
Gilead Sciences Inc
NASDAQ:GILD
$151.55
-%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
$525.4
-0.43%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
$752.25
-%
Moderna Inc
NASDAQ:MRNA
$195
-1.17%
argenx SE
NASDAQ:ARGX
$955.31
-1.77%
Natera Inc
NASDAQ:NTRA
$411.75
0%
Revolution Medicines Inc
NASDAQ:RVMD
$201.74
-%
BeOne Medicines Ltd
NASDAQ:ONC
$361.09
-1.64%
Mostra tutte le 10 aziende correlate